Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis
Public ClinicalTrials.gov record NCT05133336. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-blind, Placebo Controlled, Phase 2b/3 Study to Evaluate the Efficacy and Safety of Saroglitazar Magnesium in Subjects With Primary Biliary Cholangitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Saroglitazar Magnesium 1 mg and 2 mg tablets for treatment of subjects with Primary Biliary Cholangitis (PBC)
Study identification
- NCT ID
- NCT05133336
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 196 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 1, 2022 (Actual)
- Primary completion
- Apr 30, 2025 (Actual)
- Completion
- May 7, 2025 (Actual)
- Last update posted
- Sep 17, 2026
2022 – 2025
United States locations
- U.S. sites
- 31
- U.S. states
- 21
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Zydus US007 | Birmingham | Alabama | 35233 | — |
| Zydus US021 | Tucson | Arizona | 85724 | — |
| Zydus US013 | Los Angeles | California | 90048 | — |
| Zydus US011 | Pasadena | California | 91105 | — |
| Zydus US043 | Sacramento | California | 95817 | — |
| Zydus US022 | Aurora | Colorado | 80045 | — |
| Zydus US037 | New Haven | Connecticut | 06510 | — |
| Zydus US027 | Jacksonville | Florida | 32224 | — |
| Zydus US006 | Lakewood Rch | Florida | 34211 | — |
| Zydus US005 | Miami | Florida | 33136 | — |
| Zydus US028 | Sarasota | Florida | 34201 | — |
| Zydus US019 | Tampa | Florida | 33606 | — |
| Zydus US020 | Marietta | Georgia | 30060 | — |
| Zydus US001 | Indianapolis | Indiana | 46202 | — |
| Zydus US034 | Iowa City | Iowa | 52242 | — |
| Zydus US036 | Marrero | Louisiana | 70072 | — |
| Zydus US023 | Rochester | Minnesota | 55905 | — |
| Zydus US030 | St Louis | Missouri | 63104 | — |
| Zydus US024 | Omaha | Nebraska | 68198 | — |
| Zydus US038 | Manhasset | New York | 11030 | — |
| Zydus US035 | Rochester | New York | 14642 | — |
| Zydus US002 | Charlotte | North Carolina | 28204 | — |
| Zydus US014 | Cincinnati | Ohio | 45044 | — |
| Zydus US015 | Philadelphia | Pennsylvania | 19141 | — |
| Zydus US004 | Houston | Texas | 77030 | — |
| Zydus US042 | Houston | Texas | 77030 | — |
| Zydus US031 | Murray | Utah | 84107 | — |
| Zydus US016 | Charlottesville | Virginia | 22908 | — |
| Zydus US041 | Newport News | Virginia | 23602 | — |
| Zydus US039 | Richmond | Virginia | 23298 | — |
| Zydus US033 | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 26 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05133336, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 17, 2026 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05133336 live on ClinicalTrials.gov.